Table 3.
Exposure score 0–1 | Exposure score > 1 | ||||
---|---|---|---|---|---|
Cases/non-cases (n) | OR (95% CI) | Cases/non-cases (n) | Crude OR (95% CI) | Adjusted OR5 (95% CI) | |
Allergies | 14/26 | 1.00 | 35/24 | 2.71 (1.18–6.22)* | 1.23 (0.43–3.54) |
Native American | 5/6 | 1.00 | 17/34 | 2.40 (0.64–9.00) | 2.46 (0.65–9.30) |
Asthma | 10/30 | 1.00 | 43/21 | 6.14 (2.53–14.89)** | 2.03 (0.64–6.41) |
Native American | 4/6 | 1.00 | 43/13 | 4.96 (1.21–20.30)* | 6.16 (1.38–27.49)* |
Bronchitis | 5/34 | 1.00 | 33/27 | 8.31 (2.86–24.17)** | 4.10 (1.18–14.23)* |
Native American | 1/9 | 1.00 | 33/19 | 15.63 (1.84–133.09)* | 17.42 (1.99–152.45)* |
Arthritis | 12/28 | 1.00 | 37/24 | 3.60 (1.54–8.41)** | 2.57 (0.80–8.23) |
Native American | 5/6 | 1.00 | 34/19 | 2.15 (0.58–7.98) | 2.32 (0.58–9.31) |
Heart disease | 8/34 | 1.00 | 26/37 | 2.99 (1.19–7.49)* | 1.98 (0.59–6.63) |
Native American | 4/7 | 1.00 | 23/31 | 1.30 (0.34–4.97) | 1.49 (0.34–6.49) |
High blood pressure | 15/27 | 1.00 | 52/17 | 5.51 (2.39–12.70)** | 2.81 (0.87–9.08) |
Native American | 9/2 | 1.00 | 47/13 | 0.80 (0.15–4.19) | 0.88 (0.13–5.78) |
Type 2 diabetes | 7/34 | 1.00 | 18/43 | 2.03 (0.76–5.43) | 0.72 (0.19–2.73) |
Native American | 5/6 | 1.00 | 17/36 | 0.57 (0.15–2.12) | 0.54 (0.13–2.31) |
p-value < 0.05
p-value < 0.01